Diabetomics Inc. Changes Name to Modality Dx Amid New Innovation and Expansion of Molecular Signature Diagnosis Products
PORTLAND, Ore.--(BUSINESS WIRE)--Diabetomics has been rebranded Modality Dx. Founded by Dr. Srinivasa Nagalla, Modality Dx is an innovator in rapid test technologies for risk assessment and diagnos...
2 months ago